CS294791A3 - Fibrinogen receptor antagonists - Google Patents

Fibrinogen receptor antagonists Download PDF

Info

Publication number
CS294791A3
CS294791A3 CS912947A CS294791A CS294791A3 CS 294791 A3 CS294791 A3 CS 294791A3 CS 912947 A CS912947 A CS 912947A CS 294791 A CS294791 A CS 294791A CS 294791 A3 CS294791 A3 CS 294791A3
Authority
CS
Czechoslovakia
Prior art keywords
compound
formula
pharmaceutically acceptable
asp
fibrinogen
Prior art date
Application number
CS912947A
Other languages
Czech (cs)
English (en)
Inventor
Mark E Duggan
Original Assignee
Merck & Co Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck & Co Inc filed Critical Merck & Co Inc
Publication of CS294791A3 publication Critical patent/CS294791A3/cs

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K9/00—Peptides having up to 20 amino acids, containing saccharide radicals and having a fully defined sequence; Derivatives thereof
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/02—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/745—Blood coagulation or fibrinolysis factors
    • C07K14/75—Fibrinogen
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/08—Tripeptides
    • C07K5/0802—Tripeptides with the first amino acid being neutral
    • C07K5/0804—Tripeptides with the first amino acid being neutral and aliphatic
    • C07K5/0806—Tripeptides with the first amino acid being neutral and aliphatic the side chain containing 0 or 1 carbon atoms, i.e. Gly, Ala
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • General Chemical & Material Sciences (AREA)
  • Zoology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Toxicology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
CS912947A 1990-09-27 1991-09-26 Fibrinogen receptor antagonists CS294791A3 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US58928290A 1990-09-27 1990-09-27

Publications (1)

Publication Number Publication Date
CS294791A3 true CS294791A3 (en) 1992-04-15

Family

ID=24357362

Family Applications (1)

Application Number Title Priority Date Filing Date
CS912947A CS294791A3 (en) 1990-09-27 1991-09-26 Fibrinogen receptor antagonists

Country Status (15)

Country Link
EP (1) EP0479481A3 (fi)
JP (1) JPH0517498A (fi)
KR (1) KR920006373A (fi)
CN (1) CN1060293A (fi)
AU (1) AU8477891A (fi)
CA (1) CA2052057A1 (fi)
CS (1) CS294791A3 (fi)
FI (1) FI914532A (fi)
HU (1) HUT60751A (fi)
IE (1) IE913380A1 (fi)
IL (1) IL99539A0 (fi)
MX (1) MX9101311A (fi)
NO (1) NO913786L (fi)
PT (1) PT99095A (fi)
ZA (1) ZA917695B (fi)

Families Citing this family (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5939412A (en) * 1992-06-26 1999-08-17 Smithkline Beecham Corporation Bicyclic fibrinogen antagonists
ZA924760B (en) * 1991-06-28 1993-03-31 Smithkline Beecham Corp Bicyclic fibrinogen antagonists
US5340798A (en) * 1992-10-14 1994-08-23 Merck & Co., Inc. Fibrinogen receptor antagonists
ATE188379T1 (de) * 1992-10-14 2000-01-15 Merck & Co Inc Fibrinogenrezeptor-antagonisten
AU674553B2 (en) * 1992-10-14 1997-01-02 Merck & Co., Inc. Fibrinogen receptor antagonists
US5358956A (en) * 1992-10-14 1994-10-25 Merck & Co., Inc. Fibrinogen receptor antagonists
AU675689B2 (en) * 1992-12-01 1997-02-13 Merck & Co., Inc. Fibrinogen receptor antagonists
US5750754A (en) * 1993-03-29 1998-05-12 Zeneca Limited Heterocyclic compounds
ZW4194A1 (en) * 1993-03-29 1994-12-21 Zeneca Ltd Heterocyclic compounds
US5652242A (en) * 1993-03-29 1997-07-29 Zeneca Limited Heterocyclic derivatives
US5753659A (en) * 1993-03-29 1998-05-19 Zeneca Limited Heterocyclic compouds
DE69411900T2 (de) * 1993-03-29 1998-12-10 Zeneca Ltd., London Heterozyklische derivate als plätchenaggregationsinhibitoren
US5334596A (en) * 1993-05-11 1994-08-02 Merck & Co., Inc. Fibrinogen receptor antagonists
US5463011A (en) * 1993-06-28 1995-10-31 Zeneca Limited Acid derivatives
GB9313285D0 (en) * 1993-06-28 1993-08-11 Zeneca Ltd Acid derivatives
GB9313268D0 (en) * 1993-06-28 1993-08-11 Zeneca Ltd Chemical compounds
US5397791A (en) * 1993-08-09 1995-03-14 Merck & Co., Inc. Fibrinogen receptor antagonists
US6274705B1 (en) 1996-05-02 2001-08-14 Aventis Pharmaceuticals Products Inc. Antithrombotic azacycloalkylalkanoyl peptides and pseudopeptides
US5780590A (en) * 1993-10-15 1998-07-14 Rhone-Poulenc Rorer Pharmaceuticals Inc. Antithrombotic azacycloalkylalkanoyl peptides and pseudopeptides
JP3032297B2 (ja) * 1993-10-15 2000-04-10 ローヌ‐プーラン ローラー ファーマシューティカルズ インコーポレイテッド 抗血栓性アザシクロアルキルアルカノイルペプチド及びプソイドペプチド
MA23420A1 (fr) * 1994-01-07 1995-10-01 Smithkline Beecham Corp Antagonistes bicycliques de fibrinogene.
US6458784B1 (en) 1994-06-29 2002-10-01 Smithkline Beecham Corporation Vitronectin receptor antagonists
US5451578A (en) * 1994-08-12 1995-09-19 Merck & Co., Inc. Fibrinogen receptor antagonists
US5525617A (en) * 1994-08-24 1996-06-11 Merck & Co., Inc. Fibrinogen receptor antagonists
US5977101A (en) * 1995-06-29 1999-11-02 Smithkline Beecham Corporation Benzimidazoles/Imidazoles Linked to a Fibrinogen Receptor Antagonist Template Having Vitronectin Receptor Antagonist Activity
US5789421A (en) * 1995-10-26 1998-08-04 Merck & Co., Inc. Fibrinogen receptor antagonist
US5780480A (en) * 1996-02-28 1998-07-14 Merck & Co., Inc. Fibrinogen receptor antagonists
KR100512671B1 (ko) * 1996-11-27 2005-09-07 아벤티스 파마슈티칼스 인크. 항 Ｘａ 활성을 지닌 화합물 및 혈소판 응집 길항제 화합물을포함하는 약제학적 조성물
EP1747219A4 (en) * 2004-05-13 2010-05-26 Glaxo Group Ltd Antagonists of muscarinic acetylcholine receptor

Also Published As

Publication number Publication date
NO913786D0 (no) 1991-09-26
EP0479481A2 (en) 1992-04-08
NO913786L (no) 1992-03-30
CA2052057A1 (en) 1992-03-28
JPH0517498A (ja) 1993-01-26
PT99095A (pt) 1992-08-31
AU8477891A (en) 1992-04-02
KR920006373A (ko) 1992-04-27
FI914532A0 (fi) 1991-09-26
IE913380A1 (en) 1992-04-08
HUT60751A (en) 1992-10-28
CN1060293A (zh) 1992-04-15
MX9101311A (es) 1992-05-04
IL99539A0 (en) 1992-08-18
FI914532A (fi) 1992-03-28
EP0479481A3 (en) 1993-07-28
HU913074D0 (en) 1992-01-28
ZA917695B (en) 1992-05-27

Similar Documents

Publication Publication Date Title
CS294791A3 (en) Fibrinogen receptor antagonists
EP0478362B1 (en) Fibrinogen receptor antagonists
AU636426B2 (en) Anti-thrombotic peptides and pseudopeptides
US4885283A (en) Phosphinic acid derivatives
US5120859A (en) Chimeric amino acid analogues
US4952562A (en) Anti-thrombotic peptides and pseudopeptides
US5374622A (en) Fibrinogen receptor antagonists
US6858577B1 (en) Indole peptidomimetics as thrombin receptor antagonists
US5264420A (en) Fibrinogen receptor antagonists
US5051405A (en) Anti-thrombotic peptides and pseudopeptides
US5064814A (en) Anti-thrombotic peptide and pseudopeptide derivatives
IE921463A1 (en) Fibrinogen receptor antagonists
JPH07116144B2 (ja) フィブリノーゲン受容体拮抗薬
JPH07278095A (ja) アルギニンアルデヒドの亜硫酸水素塩付加物
CZ291690B6 (cs) Inhibitory serinové proteázy a farmaceutický prostředek
RU2178419C2 (ru) Ингибиторы протеазы серина
EP0570507A1 (en) Anti-aggregatory peptides containing an aromatic ester or amide
CZ277998A3 (cs) Inhibitory serinproteázy a farmaceutický prostředek
CA2066047A1 (en) Anti-thrombotic peptides and pseudopeptides
WO2000002903A1 (en) Cs-1 peptidomimetics, compositions and methods of using the same
US5610142A (en) Bradykinin antagonist pseudopeptide derivatives of substituted 4-keto-1,3,8-triazaspiro[4.5]decan-3-alkanoic acids
US5856309A (en) Amidinopyrroline derivatives, processes for their production and pharmaceutical agents containing these compounds
US5328900A (en) Anti-thrombotic peptide and pseudopeptide derivatives